Skip to main content
. 2022 Nov 8;12(11):1871. doi: 10.3390/jpm12111871

Table 2.

Patient outcomes.

Variables * COVID-19
Prematurity Group (n = 61)
COVID-19
No Prematurity Group (n = 124)
No COVID-19
Prematurity
Group (n = 243)
p-Value
Complications during previous pregnancies
Pregnancy-associated DM 3 (4.9%) 7 (5.6%) 11 (4.5%) 0.895
Gestational hypertension 6 (9.8%) 3 (2.4%) 23 (9.5%) 0.039
Preeclampsia 2 (3.3%) 1 (0.8%) 8 (3.3%) 0.338
Abnormal placental implantation 4 (6.6%) 3 (2.4%) 13 (5.3%) 0.341
PROM 5 (8.2%) 2 (1.6%) 19 (7.8%) 0.047
UTIs 11 (18.0%) 13 (10.5%) 54 (22.2%) 0.022
Cesarean delivery 14 (23.0%) 22 (17.7%) 55 (22.6%) 0.523
Oligohydramnios 0 (0.0%) 1 (0.8%) 6 (2.5%) 0.273
Polyhydramnios 2 (3.3%) 2 (1.6%) 11 (4.5%) 0.354
Anemia 12 (19.7%) 18 (14.5%) 52 (21.4%) 0.283
Endometritis 2 (3.3%) 0 (0.0%) 7 (2.9%) 0.150
Trimester of SARS-CoV-2 infection 0.005
1st trimester 9 (14.8%) 47 (37.9%)
2nd trimester 23 (37.7%) 37 (29.8%)
3rd trimester 29 (47.5%) 40 (32.3%)
Symptomatic SARS-CoV-2 infection 0.021
Yes 40 (76.4%) 59 (47.6%)
No 21 (23.6%) 65 (52.4%)
Current pregnancy complications
Pregnancy-associated DM 4 (6.6%) 6 (4.8%) 18 (7.4%) 0.642
Gestational hypertension 7 (9.8%) 1 (0.8%) 26 (10.7%) 0.002
Preeclampsia 1 (1.6%) 2 (1.6%) 5 (2.1%) 0.946
Abnormal placental implantation 2 (3.3%) 3 (2.4%) 13 (5.3%) 0.341
PROM 6 (9.8%) 2 (1.6%) 17 (7.0%) 0.040
UTIs 13 (21.3%) 14 (11.3%) 58 (23.9%) 0.016
Cesarean delivery 16 (26.2%) 25 (20.2%) 61 (25.1%) 0.514
Oligohydramnios 2 (3.3%) 0 (0.0%) 6 (2.5%) 0.173
Polyhydramnios 3 (4.9%) 1 (0.8%) 7 (2.9%) 0.219
Anemia 15 (24.6%) 16 (12.9%) 59 (24.3%) 0.031
Endometritis 4 (6.6%) 4 (3.2%) 12 (4.9%) 0.574

* Data is presented as n (%) unless specified differently; UTI—Urinary Tract Infections; DM—Diabetes Mellitus; PROM—Premature Rupture of Membranes.